Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease

被引:170
|
作者
Mungas, D
Reed, BR
Jagust, WJ
DeCarli, C
Mack, WJ
Kramer, JH
Weiner, MW
Schuff, N
Chui, HC
机构
[1] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA
[2] Univ So Calif, Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA
[3] Univ So Calif, Sch Med, Dept Neurol, Los Angeles, CA 90089 USA
[4] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Sch Med, Dept Radiol, San Francisco, CA 94143 USA
[6] Dept Vet Affairs Med Ctr, Magnet Resonance Unit, San Francisco, CA USA
关键词
D O I
10.1212/WNL.59.6.867
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To examine volumetric MRI correlates of longitudinal cognitive decline in normal aging, AD, and 'subcortical cerebrovascular brain injury (SCVBI). Background: Previous cross-sectional studies examining the relationship between cognitive impairment and dementia have shown that hippocampal and cortical gray matter atrophy are the most important predictors of cognitive impairment, even in cases with SCVBI. The authors hypothesized that hippocampal and cortical gray matter volume also would. best predict rate of cognitive decline in cases with and without SCVBI. Methods: Subjects were recruited for a multicenter study of contributions to dementia of AD and SCVBI. The sample (n = 120) included cognitively normal, cognitively impaired, and demented cases with and without lacunes identified by MRI. Cases with cortical strokes were excluded. Average length of follow-up was 3.0 years. Measures of hippocampal volume, volume of cortical gray matter, presence of subcortical lacunes, and volume of white matter hyperintensity were derived from MRI. Random effects modeling of longitudinal data was used to assess effects of baseline MRI variables on longitudinal change in a measure of global cognitive ability. Results: Cortical gray matter atrophy predicted cognitive decline regardless of whether lacunes were present. Hippocampal atrophy predicted decline only in those without lacunes. Neither lacunes nor white matter hyperintensity independently predicted decline. Conclusions: Results suggest that cortical atrophy is an index of disease severity in both AD and subcortical cerebrovascular brain injury and consequently predicts faster progression. Hippocampal volume may index disease severity and predict progression in AD. The absence of this effect in cases with lacunes suggests that this group is etiologically heterogeneous and is not composed simply of cases of AD with incidental stroke.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 50 条
  • [31] TEMPORAL-LOBE PERFUSION ON SPECT PREDICTS THE RATE OF COGNITIVE DECLINE IN ALZHEIMERS-DISEASE
    WOLFE, N
    REED, BR
    JAGUST, WJ
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1993, 15 (01) : 71 - 71
  • [32] Regional volumetric change in Parkinson's disease with cognitive decline
    Gee, Myrlene
    Dukart, Juergen
    Draganski, Bogdan
    Martin, W. R. Wayne
    Emery, Derek
    Camicioli, Richard
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 : 88 - 94
  • [33] ASSOCIATION OF SUBCLINICAL CEREBROVASCULAR DISEASE WITH RATE OF DECLINE IN GAIT PERFORMANCE
    Wu, S.
    Hirsch, C.
    Durbin-Johnson, B.
    Buzkova, P.
    Patel, K.
    Xia, J.
    GERONTOLOGIST, 2012, 52 : 212 - 212
  • [34] Editors' Note: Predicting Cognitive Decline in Older Adults Using Baseline Metrics of AD Pathologies, Cerebrovascular Disease, and Neurodegeneration
    Lewis, Ariane
    Galetta, Steven
    NEUROLOGY, 2023, 101 (07) : 333 - 334
  • [35] Cognitive Decline and Dementia Related to Cerebrovascular Diseases: Some Evidence and Concepts
    Pantoni, Leonardo
    Poggesi, Anna
    Inzitari, Domenico
    CEREBROVASCULAR DISEASES, 2009, 27 : 191 - 196
  • [36] The rate of cognitive decline in Parkinson's disease
    Aarsland, D
    Andersen, K
    Larsen, JP
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 33 - 33
  • [37] Focal temporal lobe dysfunction in probable Alzheimer's disease predicts a slow rate of cognitive decline
    Butters, MA
    Lopez, OL
    Becker, JT
    NEUROLOGY, 1996, 46 (03) : 687 - 692
  • [38] Subclinical Cerebrovascular Disease and Cognitive Decline Response to Letter by Hadjiev and Mineva
    Wendell, Carrington Rice
    Zonderman, Alan B.
    Metter, E. Jeffrey
    Najjar, Samer S.
    Waldstein, Shari R.
    STROKE, 2010, 41 (02) : E113 - E113
  • [39] Implicit category learning performance predicts rate of cognitive decline in nondemented patients with Parkinson's disease
    Filoteo, J. Vincent
    Maddox, W. Todd
    Salmon, David P.
    Song, David D.
    NEUROPSYCHOLOGY, 2007, 21 (02) : 183 - 192
  • [40] Variations in regulatory regions of APOE affect the rate of cognitive decline in AD
    Nature Clinical Practice Neurology, 2007, 3 (10): : 534 - 534